Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial.
about
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Variation in Patient Profiles ...... tion (CHAMPION) PHOENIX Trial.
@en
Variation in Patient Profiles ...... agement of Platelet Inhibition
@nl
type
label
Variation in Patient Profiles ...... tion (CHAMPION) PHOENIX Trial.
@en
Variation in Patient Profiles ...... agement of Platelet Inhibition
@nl
prefLabel
Variation in Patient Profiles ...... tion (CHAMPION) PHOENIX Trial.
@en
Variation in Patient Profiles ...... agement of Platelet Inhibition
@nl
P2093
P2860
P1476
Variation in Patient Profiles ...... tion (CHAMPION) PHOENIX Trial.
@en
P2093
C Michael Gibson
Christian W Hamm
Deepak L Bhatt
Efthymios N Deliargyris
Gregg W Stone
Harvey D White
Jayne Prats
Matthew J Price
Muthiah Vaduganathan
Ph Gabriel Steg
P2860
P356
10.1161/CIRCINTERVENTIONS.116.003612
P577
2016-06-01T00:00:00Z